Reproductive health in adults with congenital heart disease: a review on fertility, sexual health, assisted reproductive technology and contraception

References

• Bouma BJ, Mulder BJM. Changing landscape of congenital heart disease. Circ Res. 2017;120(6):908–922. doi: 10.1161/CIRCRESAHA.116.309302
   PubMed Web of Science ®Google Scholar
• van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241–2247. doi: 10.1016/j.jacc.2011.08.025
   PubMed Web of Science ®Google Scholar
• Wu W, He J, Shao X. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990-2017. Medicine (Baltimore). 2020;99(23):e20593. doi: 10.1097/MD.0000000000020593
   PubMed Web of Science ®Google Scholar
• Collaborators GBDCo D, Abate D, Abate KH. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736–1788. doi: 10.1016/S0140-6736(18)32203-7
   PubMed Web of Science ®Google Scholar
• Moons P, Bovijn L, Budts W, et al. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122(22):2264–2272. doi: 10.1161/CIRCULATIONAHA.110.946343
   PubMed Web of Science ®Google Scholar
• Baumgartner H, De Backer J. The ESC clinical practice guidelines for the management of adult congenital heart disease 2020. Eur Heart J. 2020;41(43):4153–4154. doi: 10.1093/eurheartj/ehaa701
   PubMed Web of Science ®Google Scholar
• Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(12):1494–1563. doi: 10.1016/j.jacc.2018.08.1028
   PubMed Web of Science ®Google Scholar
• Skakkebaek NE, Lindahl-Jacobsen R, Levine H, et al. Environmental factors in declining human fertility. Nat Rev Endocrinol. 2022;18(3):139–157. doi: 10.1038/s41574-021-00598-8
   PubMed Web of Science ®Google Scholar
• (WHO) WHO. International Classification of Diseases, 11th Revision (ICD-11). Geneva: WHO; 2018.
   Google Scholar
• Winters BR, Walsh TJ. The epidemiology of male infertility. Urol Clin North Am. 2014;41(1):195–204. doi: 10.1016/j.ucl.2013.08.006
   PubMed Web of Science ®Google Scholar
• Abrao MS, Muzii L, Marana R. Anatomical causes of female infertility and their management. Int J Gynaecol Obstet. 2013;123 Suppl 2:S18–24. doi: 10.1016/j.ijgo.2013.09.008
   PubMed Web of Science ®Google Scholar
• Homan GF, Davies M, Norman R. The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment: a review. Hum Reprod Update. 2007;13(3):209–223. doi: 10.1093/humupd/dml056
   PubMed Web of Science ®Google Scholar
• Mascarenhas MN, Flaxman SR, Boerma T, et al. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLOS Med. 2012;9(12):e1001356. doi: 10.1371/journal.pmed.1001356
   PubMed Web of Science ®Google Scholar
• Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Pregnancy and delivery in women after Fontan palliation. Heart. 2006;92(9):1290–1294. doi: 10.1136/hrt.2005.085407
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–3241. doi: 10.1093/eurheartj/ehy340
   PubMed Web of Science ®Google Scholar
• Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20(3):370–385. doi: 10.1093/humupd/dmt062
   PubMed Web of Science ®Google Scholar
• Matsushita KA, Izumi M, Miyake C, et al. Reduced ovarian function in women with complex congenital heart disease. Int J Cardiol Congenit Heart Dis. 2022;7(100317):100317. doi: 10.1016/j.ijcchd.2021.100317
   Google Scholar
• Gouton M, Nizard J, Patel M, et al. Maternal and fetal outcomes of pregnancy with Fontan circulation: a multicentric observational study. Int J Cardiol. 2015;187:84–89. doi: 10.1016/j.ijcard.2015.03.344
   PubMed Web of Science ®Google Scholar
• Chien SJ, Lin YJ, Lo MH, et al. Congenital heart diseases impair female fertility. Front Pediatr. 2021;9:687276. doi: 10.3389/fped.2021.687276
   PubMed Web of Science ®Google Scholar
• Udholm LF, Arendt LH, Knudsen UB, et al. Congenital heart disease and fertility: a Danish nationwide cohort study including both men and women. J Am Heart Assoc. 2023;12(2):e027409. doi: 10.1161/JAHA.122.027409
   PubMed Web of Science ®Google Scholar
• Opic P, Roos-Hesselink JW, Cuypers JA, et al. Sexual functioning is impaired in adults with congenital heart disease. Int J Cardiol. 2013;168(4):3872–3877. doi: 10.1016/j.ijcard.2013.06.029
   PubMed Web of Science ®Google Scholar
• Canobbio MM, Rapkin AJ, Perloff JK, et al. Menstrual patterns in women with congenital heart disease. Pediatr Cardiol. 1995;16(1):12–15. doi: 10.1007/BF02310327
   PubMed Web of Science ®Google Scholar
• Drenthen W, Hoendermis ES, Moons P, et al. Menstrual cycle and its disorders in women with congenital heart disease. Congenit Heart Dis. 2008;3(4):277–283. doi: 10.1111/j.1747-0803.2008.00202.x
   PubMedGoogle Scholar
• Vigl M, Kaemmerer M, Niggemeyer E, et al. Sexuality and reproductive health in women with congenital heart disease. Am J Cardiol. 2010;105(4):538–541. doi: 10.1016/j.amjcard.2009.10.025
   PubMed Web of Science ®Google Scholar
• Cook SC, Arnott LM, Nicholson LM, et al. Erectile dysfunction in men with congenital heart disease. Am J Cardiol. 2008;102(12):1728–1730. doi: 10.1016/j.amjcard.2008.08.017
   PubMed Web of Science ®Google Scholar
• Vigl M, Hager A, Bauer U, et al. Sexuality and subjective wellbeing in male patients with congenital heart disease. Heart. 2009;95(14):1179–1183. doi: 10.1136/hrt.2008.156695
   PubMed Web of Science ®Google Scholar
• Shiri R, Koskimaki J, Hakkinen J, et al. Cardiovascular drug use and the incidence of erectile dysfunction. Int J Impot Res. 2007;19(2):208–212. doi: 10.1038/sj.ijir.3901516
   PubMed Web of Science ®Google Scholar
• Fischer AJ, Grundlach C, Helm PC, et al. Erectile dysfunction in men with adult congenital heart disease: a prevalent but neglected issue. Korean Circ J. 2022;52(3):233–242. doi: 10.4070/kcj.2021.0184
   PubMed Web of Science ®Google Scholar
• Zegers-Hochschild F, Adamson GD, de Mouzon J, et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril. 2009;92(5):1520–1524. doi: 10.1016/j.fertnstert.2009.09.009
   PubMed Web of Science ®Google Scholar
• Kushnir VA, Barad DH, Albertini DF, et al. Systematic review of worldwide trends in assisted reproductive technology 2004-2013. Reprod Biol Endocrinol. 2017;15(1):6. doi: 10.1186/s12958-016-0225-2
   PubMedGoogle Scholar
• Qin J, Liu X, Sheng X, et al. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. Fertil Steril. 2016;105(1):73-85 e1–6. doi:10.1016/j.fertnstert.2015.09.007
   Web of Science ®Google Scholar
• Helmerhorst FM, Perquin DA, Donker D, et al. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ. 2004;328(7434):261. doi: 10.1136/bmj.37957.560278.EE
   PubMed Web of Science ®Google Scholar
• Pandey S, Shetty A, Hamilton M, et al. Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(5):485–503. doi: 10.1093/humupd/dms018
   PubMed Web of Science ®Google Scholar
• El-Shawarby S, Margara R, Trew G, et al. A review of complications following transvaginal oocyte retrieval for in-vitro fertilization. Hum Fertil (Camb). 2004;7(2):127–133. doi: 10.1080/14647270410001699081
   PubMedGoogle Scholar
• Fujitake E, Jaspal R, Monasta L, et al. Acute cardiovascular changes in women undergoing in vitro fertilisation (IVF), a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;248:245–251. doi: 10.1016/j.ejogrb.2020.01.033
   PubMed Web of Science ®Google Scholar
• Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124–2132. doi: 10.1093/eurheartj/ehq200
   PubMed Web of Science ®Google Scholar
• Gnanaraj JAP, Surendran A, Susikar A, et al. Pregnancy outcomes in women with heart disease: the madras medical college pregnancy and cardiac (M-PAC) Registry from India. Eur Heart J. 2023;44(17):1530–1540. doi: 10.1093/eurheartj/ehad003
   Web of Science ®Google Scholar
• Roos-Hesselink J, Baris L, Johnson M, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry of Pregnancy and Cardiac disease (ROPAC). Eur Heart J. 2019;40(47):3848–3855. doi: 10.1093/eurheartj/ehz136
   PubMed Web of Science ®Google Scholar
• Silversides CK, Grewal J, Mason J, et al. Pregnancy outcomes in women with heart disease: the CARPREG II Study. J Am Coll Cardiol. 2018;71(21):2419–2430. doi: 10.1016/j.jacc.2018.02.076
   PubMed Web of Science ®Google Scholar
• Lu CW, Shih JC, Chen SY, et al. Comparison of 3 risk estimation methods for predicting cardiac outcomes in pregnant women with congenital heart disease. Circ J. 2015;79(7):1609–1617. doi: 10.1253/circj.CJ-14-1368
   PubMed Web of Science ®Google Scholar
• Dayan N, Laskin CA, Spitzer K, et al. Pregnancy complications in women with heart disease conceiving with fertility therapy. J Am Coll Cardiol. 2014;64(17):1862–1864. doi: 10.1016/j.jacc.2014.07.977
   PubMed Web of Science ®Google Scholar
• Quien MM, Hausvater A, Maxwell SM, et al. Assisted reproductive technology outcomes in women with heart disease. Front Cardiovasc Med. 2022;9:842556. doi: 10.3389/fcvm.2022.842556
   PubMed Web of Science ®Google Scholar
• Skorupskaite K, Joy E, Balen A, et al. Assisted reproduction in patients with cardiac disease: a retrospective review. Eur J Obstet Gynecol Reprod Biol. 2022;276:199–203. doi: 10.1016/j.ejogrb.2022.07.020
   PubMed Web of Science ®Google Scholar
• Costello MF, Horrowitz S, Steigrad S, et al. Transcervical intrauterine topical local anesthetic at hysterosalpingography: a prospective, randomized, double-blind, placebo-controlled trial. Fertil Steril. 2002;78(5):1116–1122. doi: 10.1016/S0015-0282(02)03362-9
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Mansour D, Fiala C, et al. Management of pain associated with the insertion of intrauterine contraceptives. Hum Reprod Update. 2013;19(4):419–427. doi: 10.1093/humupd/dmt022
   PubMed Web of Science ®Google Scholar
• Joris JL, Noirot DP, Legrand MJ, et al. Hemodynamic changes during laparoscopic cholecystectomy. Anesth Analg. 1993;76(5):1067–1071. doi: 10.1213/00000539-199305000-00027
   PubMed Web of Science ®Google Scholar
• Snabes MC, Poindexter AN 3rd. Laparoscopic tubal sterilization under local anesthesia in women with cyanotic heart disease. Obstet Gynecol. 1991;78(3 Pt 1):437–440.
   PubMed Web of Science ®Google Scholar
• Van Eyk N, van Schalkwyk JN. 275-antibiotic prophylaxis in gynaecologic procedures. J Obstet Gynaecol Can. 2018;40(10):e723–e33. doi: 10.1016/j.jogc.2018.07.007
   PubMed Web of Science ®Google Scholar
• Ujvari D, Hulchiy M, Calaby A, et al. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome. Hum Reprod. 2014;29(7):1526–1535. doi: 10.1093/humrep/deu114
   PubMed Web of Science ®Google Scholar
• Balen AH. Ovulation induction in the management of anovulatory polycystic ovary syndrome. Mol Cell Endocrinol. 2013;373(1–2):77–82. doi: 10.1016/j.mce.2012.10.008
   PubMed Web of Science ®Google Scholar
• Weiss NS, Nahuis M, Bayram N, et al. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome. Cochrane Database Of Systematic Reviews. 2015;2015(9):CD010290. doi: 10.1002/14651858.CD010290.pub2
   Google Scholar
• Lin H, Li Y, Li L, et al. Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs. PLoS ONE. 2014;9(3):e91796. doi: 10.1371/journal.pone.0091796
   PubMed Web of Science ®Google Scholar
• Manau D, Balasch J, Arroyo V, et al. Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators. J Clin Endocrinol Metab. 1998;83(5):1489–1493. doi: 10.1210/jc.83.5.1489
   PubMed Web of Science ®Google Scholar
• Chan WS, Dixon ME. The “ART” of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res. 2008;121(6):713–726. doi: 10.1016/j.thromres.2007.05.023
   PubMed Web of Science ®Google Scholar
• Farquhar C, Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2018;8(8):CD010537. doi:10.1002/14651858.CD010537.pub5
   PubMedGoogle Scholar
• Levi-Setti PE, Cirillo F, Scolaro V, et al. Appraisal of clinical complications after 23,827 oocyte retrievals in a large assisted reproductive technology program. Fertil Steril. 2018;109(6):1038–43 e1. doi: 10.1016/j.fertnstert.2018.02.002
   PubMed Web of Science ®Google Scholar
• Habib G, Lancellotti P, Antunes MJ, et al. ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–3128. doi: 10.1093/eurheartj/ehv319
   PubMed Web of Science ®Google Scholar
• Kametas NA, McAuliffe F, Krampl E, et al. Maternal cardiac function in twin pregnancy. Obstet Gynecol. 2003;102(4):806–815. doi: 10.1097/00006250-200310000-00024
   PubMed Web of Science ®Google Scholar
• Ombelet W, Martens G, De Sutter P, et al. Perinatal outcome of 12,021 singleton and 3108 twin births after non-IVF-assisted reproduction: a cohort study. Hum Reprod. 2006;21(4):1025–1032. doi: 10.1093/humrep/dei419
   PubMed Web of Science ®Google Scholar
• Ramlakhan KP, Roos-Hesselink JW. Promising perspectives on pregnancy in women with congenital heart disease. Eur Heart J. 2021;42(41):4261–4263. doi: 10.1093/eurheartj/ehab692
   PubMed Web of Science ®Google Scholar
• Flinter FA. Preimplantation genetic diagnosis. BMJ. 2001;322(7293):1008–1009. doi: 10.1136/bmj.322.7293.1008
   PubMedGoogle Scholar
• De Backer J, Bondue A, Budts W, et al. Genetic counselling and testing in adults with congenital heart disease: a consensus document of the ESC Working group of grown-up congenital heart disease, the ESC Working Group on Aorta and Peripheral Vascular Disease and the European Society of Human Genetics. Eur J Prev Cardiol. 2020;27(13):1423–1435. doi: 10.1177/2047487319854552
   PubMed Web of Science ®Google Scholar
• Zaidi S, Brueckner M. Genetics and genomics of congenital heart disease. Circ Res. 2017;120(6):923–940. doi: 10.1161/CIRCRESAHA.116.309140
   PubMed Web of Science ®Google Scholar
• Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002;8(6):559–577. doi: 10.1093/humupd/8.6.559
   PubMed Web of Science ®Google Scholar
• Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril. 2010;94(2):389–400. doi: 10.1016/j.fertnstert.2010.03.028
   PubMed Web of Science ®Google Scholar
• Humaidan P, Nelson SM, Devroey P, et al. Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials. Hum Reprod. 2016;31(9):1997–2004. doi: 10.1093/humrep/dew149
   PubMed Web of Science ®Google Scholar
• Nelson SM, Greer IA. The potential role of heparin in assisted conception. Hum Reprod Update. 2008;14(6):623–645. doi: 10.1093/humupd/dmn031
   PubMed Web of Science ®Google Scholar
• Sennstrom M, Rova K, Hellgren M, et al. Thromboembolism and in vitro fertilization - a systematic review. Acta Obstet Gynecol Scand. 2017;96(9):1045–1052. doi: 10.1111/aogs.13147
   PubMed Web of Science ®Google Scholar
• Chan WS. The ‘ART’ of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol. 2009;21(3):207–218. doi: 10.1097/GCO.0b013e328329c2b8
   PubMed Web of Science ®Google Scholar
• Henriksson P, Westerlund E, Wallen H, et al. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ. 2013;346(jan15 3):e8632. doi: 10.1136/bmj.e8632
   PubMedGoogle Scholar
• Karsenty C, Zhao A, Marijon E, et al. Risk of thromboembolic complications in adult congenital heart disease: a literature review. Arch Cardiovasc Dis. 2018;111(10):613–620. doi: 10.1016/j.acvd.2018.04.003
   PubMed Web of Science ®Google Scholar
• Dangas GD, Weitz JI, Giustino G, et al. Prosthetic Heart Valve Thrombosis. J Am Coll Cardiol. 2016;68(24):2670–2689. doi: 10.1016/j.jacc.2016.09.958
   PubMed Web of Science ®Google Scholar
• Roudaut R, Serri K, Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart. 2007;93(1):137–142. doi: 10.1136/hrt.2005.071183
   PubMed Web of Science ®Google Scholar
• Ramlakhan KP, Malhame I, Marelli A, et al. Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry. Eur Heart J. 2022;43(38):3749–3761. doi:10.1093/eurheartj/ehac308
   PubMed Web of Science ®Google Scholar
• Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):391–403. doi: 10.1016/j.bpobgyn.2011.01.006
   PubMed Web of Science ®Google Scholar
• Hayward RM, Foster E, Tseng ZH. Maternal and fetal outcomes of admission for delivery in women with congenital heart disease. JAMA Cardiol. 2017;2(6):664–671. doi: 10.1001/jamacardio.2017.0283
   PubMed Web of Science ®Google Scholar
• Tulay P, Atilan O. Oocyte donors’ awareness on donation procedure and risks: a call for developing guidelines for health tourism in oocyte donation programmes. J Turk Ger Gynecol Assoc. 2019;20(4):236–242. doi: 10.4274/jtgga.galenos.2018.2018.0110
   PubMed Web of Science ®Google Scholar
• Storgaard M, Loft A, Bergh C, et al. Obstetric and neonatal complications in pregnancies conceived after oocyte donation: a systematic review and meta-analysis. BJOG: Int J Obstet Gy. 2017;124(4):561–572. doi: 10.1111/1471-0528.14257
   PubMed Web of Science ®Google Scholar
• Reid GJ, Webb GD, Barzel M, et al. Estimates of life expectancy by adolescents and young adults with congenital heart disease. J Am Coll Cardiol. 2006;48(2):349–355. doi: 10.1016/j.jacc.2006.03.041
   PubMed Web of Science ®Google Scholar
• Marelli AJ, Mackie AS, Ionescu-Ittu R, et al. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115(2):163–172. doi: 10.1161/CIRCULATIONAHA.106.627224
   PubMed Web of Science ®Google Scholar
• Oliver JM, Gallego P, Gonzalez AE, et al. Risk factors for excess mortality in adults with congenital heart diseases. Eur Heart J. 2017;38(16):1233–1241. doi: 10.1093/eurheartj/ehw590
   PubMed Web of Science ®Google Scholar
• Brandao P, Garrido N. Commercial surrogacy: an overview gestacao de substituicao comercial: uma visao global. Rev Bras Ginecol Obstet. 2022;44(12):1141–1158. doi: 10.1055/s-0042-1759774
   PubMedGoogle Scholar
• Roos-Hesselink JW, Cornette J, Sliwa K, et al. Contraception and cardiovascular disease. Eur Heart J. 2015;36(27):1728-34, 34a–34b. doi: 10.1093/eurheartj/ehv141
   Web of Science ®Google Scholar
• Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397–404. doi: 10.1016/j.contraception.2011.01.021
   PubMed Web of Science ®Google Scholar
• Lindley KJ, Teal SB. Contraception in women with cardiovascular disease. JAMA. 2022;328(6):577–578. doi: 10.1001/jama.2022.11541
   PubMed Web of Science ®Google Scholar
• Silversides CK, Sermer M, Siu SC. Choosing the best contraceptive method for the adult with congenital heart disease. Curr Cardiol Rep. 2009;11(4):298–305. doi: 10.1007/s11886-009-0043-7
   PubMedGoogle Scholar